Geron Corp (GERN) Notes Janssen Imetelstat Trials Continuing
Tweet Send to a Friend
Geron Corporation (Nasdaq: GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE